Print
AVEG 006X; VEU 006
Trial Details:
Phase:
I
Status:
Completed
Organizer developer:
National Institute of Allergy and Infectious Diseases (NIAID)
Start Date:
March 25, 1991
Product:
MN rgp120
Antigen:
Env gp120 B
Prime 1:
MN rgp120
Prime Class:
Protein
Boost 1:
Boost 1 class:
Boost 2:
Boost 2 Class:
Boost 3:
Boost 3 Class:
Adjuvant:
Country:
USA
Volunteers:
28
ClinicalTrials.gov Identifier:
NCT00001020
Link:
http://clinicaltrials.gov/ct2/show/NCT00001020